XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Cash flows from operating activities    
Net earnings $ 109,860 $ 115,819
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 68,998 72,322
Write-off of assets relating to exit activities 8,360 3,922
Derivatives not designated in hedging relationships:    
Net (losses) gains (1,383) (421)
Cash (settlements) proceeds 40 342
Provision for doubtful accounts (720) 1,933
Deferred income taxes (716) (24)
Non-cash interest expense 1,461 1,620
Stock-based compensation 18,770 15,817
(Gain) loss on disposal of property, plant, and equipment (193) (528)
Changes in assets and liabilities:    
Accounts receivable 123,398 (40,264)
Inventories (135,905) (163,747)
Prepaid and other current assets (8,323) (18,344)
Other assets (899) 1,322
Accounts payable (31,614) (9,086)
Accrued expenses (17,149) (58,233)
Other liabilities 1,858 (480)
Net cash provided by (used in) operating activities 135,843 (78,030)
Cash flows from investing activities    
Capital expenditures (57,512) (52,351)
Proceeds from disposal of facility 0 3,268
Proceeds from termination of net investment hedges 43,384 0
Proceeds from disposal of property, plant, and equipment 452 1,433
Net cash (used in) investing activities (13,676) (47,650)
Cash flows from financing activities    
Net (repayments) borrowings on short-term debt (20,317) (297)
Proceeds from Second Amended Revolver borrowings 291,100 424,800
Repayments of Second Amended Revolver borrowings (422,082) (39,800)
Repayments of Second Amended Term Loan (1,625) (161,447)
Debt Issuance Costs 0 (2,952)
Financing costs for debt modification (1,096) 0
Option proceeds, net 1,060 1,273
Payment of taxes related to net share settlement of equity awards (6,385) (9,120)
Purchase of treasury stock (22,907) (114,534)
Dividends paid to stockholders (21,386) (22,187)
Other 842 607
Net cash (used in) provided by financing activities (202,796) 76,343
Effect of exchange rate changes on cash and cash equivalents (23,778) (5,411)
Net decrease in cash and cash equivalents (104,407) (54,748)
Cash and cash equivalents at beginning of period 402,488 451,808
Cash and cash equivalents at end of period $ 298,081 $ 397,060